ORIGINAL ARTICLE
Research on genesis of adipocytic metaplasia in uterine fibroids
More details
Hide details
Publication date: 2016-02-05
Pol J Pathol 2015;66(4):403-409
KEYWORDS
ABSTRACT
The genesis of lipoleiomyoma has not been explained yet. Immunohistochemical examinations were performed on 17 lipoleiomyomas in women aged 43-82 (mean age: 51 ±9 years). Four types of myomas were distinguished: 1) pure leiomyoma, 2) fibroleiomyoma, 3) hyalinizing leiomyoma, 4) strongly hyalinized myoma, along with three degrees of progression of adipocytic metaplasia: 1) up to 25% of lipocytes, 2) up to 50% of lipocytes, and 3) over 50% of lipocytes in the analyzed sample, along with three degrees of progression of adipocytic metaplasia: 1) up to 25% of lipocytes, 2) up to 50% of lipocytes, and 3) over 50% of lipocytes in the analyzed sample.
A positive correlation was found between the age of women and rate of development of metaplasia (r = 0.51, p = 0.035) as well as with activity of the estrogen receptor in the primary tumor (r = 0.53, p = 0.03).
New mucous perivascular tissue was reported among 11.8% of patients and on this basis lipocytes were formed.
The appearance of subendothelial granular cells of large blood vessels with a positive reaction for smooth muscle actin (SMA) and CD68 was reported in 17.7%.
Results of immunohistochemical research seem to confirm that lipocytes de novo come from the primal pluripotent cells of the tumor stroma and not from the fatty degeneration of myocytes.
REFERENCES (25)
1.
Sośnik H, Sośnik K. Investigations on uterine fatty lesions. Pol J Pathol 2013; 64: 136-143.
2.
El Amine El Hadj O, Bonraoui S, Be Fadhel CG, et al. Lipoma of the uterus: clinical and ethiopathological approach of 7 cases with immunohistohemical study of histogenesis. Tunis Med 2010; 88: 916-919.
3.
Honoré LH. Uterine fibrolipoleiomyoma; Report of a case with discussion of histogenesis. Am J Obstet Gynecol 1978; 15: 635-636.
4.
Aung T, Goto M, Nomoto M, et al. Uterine lipoleiomyoma: a histopathological review of 17 cases. Pathol Int 2004; 54: 751-758.
5.
Özdemir O. Mast cells and the tumor-associated neoangiogenesis. Med Sci Monit 2006; 12: LE 9-11.
6.
Takeuchi K, Kitazawa S, Tsujino T, et al. Uterine bizarre epithelioid lipoleiomyoma with a myxoid stroma. Eur J Gynecol Oncol 2006; 27: 273-274.
7.
Akbulut M, Soysal ME, Duzcan SE. Giant lipoleiomyoma of the uterine corpus. Arch Gynecol Obstet 2008; 278: 291-293.
8.
Akpolat I, Sertcelik A, Cӧmert S, et al. ERRP-29 and ER staining in uterine lipoma and lipoleiomyoma. Acta Oncol 1996; 35: 108.
9.
Sieiński W. Lipomatous neometaplasia of the uterus. Report of 11 cases with discussion of histogenesis and pathogenesis. Int J Gynecol Pathol 1989; 8: 357-363.
10.
Brandfass RT, Everts-Suarez EA. Lipomatous tumors of the uterus. A review of the world’s literature with report of a case of true lipoma. Am J Obstet Gynec 1955; 70: 359-367.
11.
Meinhof U, Bersch W. Beitrag zur Kenntnis der fettgewebshaltigen Uterustumoren. Zentralbl Allg Pathol 1975; 119: 369-363.
12.
Salm R. The histogenesis of uterine lipomas. Histogenese der Uteruslipome. Beitr Pathol 1973; 149: 284-292.
13.
Kaiserling E. Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology. Pathologe 2004; 25: 362-374.
14.
Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol 2002; 15: 434-440.
15.
Resta L, Maiorano E, Piscitelli D, Botticella MA. Lipomatous tumor of the uterus. Clinico-pathological features of 10 cases with immunocytochemical study of histogenesis. Path Res Pract 1994; 190: 378-383.
16.
Scully R. Smooth-muscle differentiation in genital tract disorders (Editorial). Arch Pathol Lab Med 1981; 105: 505-507.
17.
Mazur MT, Kraus FT. Histogenesis of morphologic variations in tumor of the uterine wall. Am J Surg Pathol 1980; 4: 59-74.
18.
Havel G, Wedell B, Dahlenfors R, Mark J. Cytogenetic relationship between uterine lipoleiomyomas and typical leiomyomas. Virch Arch B 1989; 57: 77-79.
19.
Hu J, Surti U, Tobon H. Cytogenetic analysis of a uterine lipoleiomyoma. Cancer Genet Cytogenet 1992; 62: 200-202.
20.
Morelli L, Pusiol T, Parolari AM, Piscioli I. Plexiform lipoleiomyoma of the uterus: first case report. Arch Gynecol Obstet 2006; 274: 117-118.
21.
Goksu Erol AY, Tokyol C, Özdemir O, et al. The role of mast cells and angiogenesis in benign and malignant neoplasms of the uterus. Pathol Res Pract 2011; 207: 618-622.
22.
Dyduch G, Okoń K, Pescarini E. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study. Pol J Pathol 2011; 62: 139-144.
23.
Özdemir O, Dağoğlu R, Goksu Erol A. Antitumor actions of human mast cells. Pol J Pathol 2012; 63: 292.
24.
Dyduch G, Kaczmarczyk K, Okoń K. Mast cells and cancer: enemies or allies? Pol J Pathol 2012; 63: 1-7.
25.
Sieinski W, Chrapusta S, Konopka B, et al. Struktura morfologiczna mięśniaków macicy a zawartość receptorów estrogenów i progestagenów. Nowotwory 1988; 38: 29-34.